Legal & General Group PLC Crispr Therapeutics Ag Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Legal & General Group PLC holds 106,925 shares of CRSP stock, worth $4.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

106,925

Previous 106,925 -0.0%

Holding current value

$4.39 Million

Previous $5.02 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $193,516 - $272,146	4,337 Added 4.23%	106,925 $5.02 Million
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $1.01 Million - $1.34 Million	19,678 Added 23.73%	102,588 $5.54 Million
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $961,437 - $1.41 Million	15,847 Added 23.63%	82,910 $5.65 Million
Q4 2023 Feb 15, 2024	SELL	$38.62 - $72.18 $3,359 - $6,279	-87 Reduced 0.13%	67,063 $4.2 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $123,233 - $160,185	2,715 Added 4.21%	67,150 $3.05 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $145,233 - $226,419	3,341 Added 5.47%	64,435 $3.62 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $247,599 - $338,908	6,039 Added 10.97%	61,094 $2.76 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $24,258 - $40,649	619 Added 1.14%	55,055 $2.24 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $53,157 - $72,888	-870 Reduced 1.57%	54,436 $3.56 Million
Q2 2022 Aug 22, 2022	BUY	$43.23 - $73.83 $113,651 - $194,099	2,629 Added 4.99%	55,306 $3.36 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $35,903 - $53,487	675 Added 1.3%	52,677 $3.31 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $302,157 - $479,771	4,311 Added 9.04%	52,002 $3.94 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.31 Million - $1.87 Million	11,926 Added 33.35%	47,691 $5.34 Million
Q2 2021 Aug 12, 2021	BUY	$100.84 - $161.89 $255,125 - $409,581	2,530 Added 7.61%	35,765 $5.79 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $426,714 - $809,494	3,854 Added 13.12%	33,235 $4.05 Million
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $97,038 - $210,994	-1,218 Reduced 3.98%	29,381 $4.5 Million
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $331,348 - $424,801	4,221 Added 16.0%	30,599 $2.56 Million
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $666,088 - $1.32 Million	17,301 Added 190.6%	26,378 $1.94 Million
Q1 2020 May 14, 2020	SELL	$33.68 - $62.53 $833,681 - $1.55 Million	-24,753 Reduced 73.17%	9,077 $428,000
Q4 2019 Feb 13, 2020	BUY	$36.68 - $73.13 $1.2 Million - $2.39 Million	32,745 Added 3017.97%	33,830 $2.06 Million
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $19,320 - $26,269	545 Added 100.93%	1,085 $51,000
Q4 2018 Feb 15, 2019	BUY	$22.73 - $42.34 $7,932 - $14,776	349 Added 182.72%	540 $15,000
Q2 2018 Aug 10, 2018	BUY	$42.62 - $73.59 $8,140 - $14,055	191 New	191 $11,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.2B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Crispr Therapeutics Ag Transaction History